The role of the poor metabolizer genotype CYP2D6 and CYP1A2 phenotype in the pharmacokinetics of duloxetine and venlafaxine-A case report.
Basic Clin Pharmacol Toxicol
; 127(4): 354-357, 2020 10.
Article
in En
| MEDLINE
| ID: mdl-32365274
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cytochrome P-450 CYP1A2
/
Cytochrome P-450 CYP2D6
/
Depression
/
Venlafaxine Hydrochloride
/
Duloxetine Hydrochloride
/
Serotonin and Noradrenaline Reuptake Inhibitors
/
Pharmacogenomic Variants
Type of study:
Diagnostic_studies
Limits:
Adult
/
Female
/
Humans
Language:
En
Journal:
Basic Clin Pharmacol Toxicol
Journal subject:
FARMACOLOGIA
/
TOXICOLOGIA
Year:
2020
Document type:
Article
Affiliation country:
Switzerland
Country of publication:
United kingdom